Core A The Administrative Core provides for essential administration, communication, and compliance responsibilities of the Exploratory Grant. It acts to promote the integration, support the Program Director and Program Administrator, organizes meetings of the Program faculty and staff, and facilitate participation in national external activities. The Administrative Core is directed by the Program Director, Dr. Standaert. He is assisted by the Center Administrator, Ms. Katherine Belue. The Core will be responsible for the coordination of the Program. Although the investigators do have established collaborative interactions, achieving the integration needed for a successful P50 Udall application will require a higher level of integration and interaction among the PI?s, their laboratory trainees and staff, and the broader community of neuroscientists and immunologists who may participate in a P50 application. The approach to coordination will include electronic communication (video conferencing and a web-based content management system for document sharing, messaging, and calendaring) as well as in person meetings. These will include biweekly meetings of the project investigators and their team. The Core will support an annual ?mini-retreat? to assist in expanding collaborations beyond the initial Exploratory Grant investigators and achieving the scope required for a successful P50. The Core will oversee sharing, regulatory compliance, and financial management. The Core will establish a web site, to communicate the activities of the Exploratory Program and maintain ties with our community partners. Training is a key component of our plans for a future Udall Center plan. All three project PI?s have current pre- and post-doctoral fellows, and close relationships with important training. We will use the support from the Exploratory Grant to strengthen these connections and promote the participation of trainees and faculty at all levels in the activities of the Exploratory Grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory Grants (P20)
Project #
5P20NS092530-02
Application #
9085429
Study Section
Special Emphasis Panel (ZNS1-SRB-J)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
$31,421
Indirect Cost
$10,046
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Delic, Vedad; Chandra, Sidhanth; Abdelmotilib, Hisham et al. (2018) Sensitivity and specificity of phospho-Ser129 ?-synuclein monoclonal antibodies. J Comp Neurol 526:1978-1990
Harms, Ashley S; Thome, Aaron D; Yan, Zhaoqi et al. (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179-187
Abdelmotilib, Hisham; Maltbie, Tyler; Delic, Vedad et al. (2017) ?-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration. Neurobiol Dis 105:84-98
Gwinn, Katrina; David, Karen K; Swanson-Fischer, Christine et al. (2017) Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomark Med 11:451-473
Harms, Ashley S; Delic, Vedad; Thome, Aaron D et al. (2017) ?-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun 5:85
West, Andrew B (2017) Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease. Exp Neurol 298:236-245
Qin, Hongwei; Buckley, Jessica A; Li, Xinru et al. (2016) Inhibition of the JAK/STAT Pathway Protects Against ?-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. J Neurosci 36:5144-59
Ponnazhagan, Ranjani; Harms, Ashley S; Thome, Aaron D et al. (2016) The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia. J Neuroimmune Pharmacol 11:231-7
Litvan, Irene; Lees, Peter S J; Cunningham, Christopher R et al. (2016) Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord 31:644-52
West, Andrew B; Cookson, Mark R (2016) Identification of bona-fide LRRK2 kinase substrates. Mov Disord 31:1140-1

Showing the most recent 10 out of 15 publications